Skip to content

Negative Oral Contrast Agents Utilization in PET/CT Studies

Negative Oral Contrast Agents Utilization in PET/CT Studies

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04577586
Enrollment
150
Registered
2020-10-08
Start date
2020-09-01
Completion date
2021-04-01
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Contrast, PET/CT

Brief summary

To compare the performance of different negative oral contrast agents in bowel distension in patient referred for PET/CT studies for various causes aiming for identification of ideal oral contrast agent(OCA).

Detailed description

Evaluation of gastrointestinal pathology depends on adequate bowel distention, which optimizes resolution of the bowel wall and contents. Traditionally, high-attenuation oral Contrast material in the form of iodine solutions or barium suspensions has been used to obtain bowel distension in MDCT examinations Traditional high-contrast oral agents like iodine solutions, and barium suspensions which due to overcorrection problems in PET-CT interpretation lowers the accuracy of diagnosis. Negative oral contrast agents like water, air, fat containing agents used with 12.5% corn oil and polyethylene glycol has been used in radiological studies. Milk with 4% fat content has also been tested out in radiological studies and found to be effective. As it is more easily available, palatable, and acceptable especially, by children it needed to be tested in the visualization of the GIT in the PET-CT studies compared to other negative contrast agents.

Interventions

OTHERoral contrast

negative oral contrast utilization in PET/CT studies

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* all patients referred to our unit for PET/CT study for various causes

Exclusion criteria

* Patients with GIT disease. * Pregnancy and lactation. * Severely ill patients.

Design outcomes

Primary

MeasureTime frameDescription
compare the performance of different negative oral contrast agents in PET/Ct studiesbaselinecomparing the effect of different oral contrast on bowel distention

Countries

Egypt

Contacts

Primary ContactNahla mostafa Bashank, Phd
nahla_bashank_2006@yahoo.com01009466255

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026